Article info
PDFCurrent controversy
Ethical considerations for epidemic vaccine trials
- Correspondence to Joshua Teperowski Monrad, Program in Ethics, Politics, and Economics, Yale University, New Haven, CT 06520, USA; joshua.monrad{at}yale.edu
Citation
Ethical considerations for epidemic vaccine trials
Publication history
- Received March 23, 2020
- Revised April 24, 2020
- Accepted May 1, 2020
- First published May 15, 2020.
Online issue publication
March 10, 2023
Article Versions
- Previous version (10 March 2023).
- Previous version (10 March 2023).
- You are viewing the most recent version of this article.
- latest version (28 April 2023).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
Other content recommended for you
- Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review
- Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo
- Forty-two years of responding to Ebola virus outbreaks in Sub-Saharan Africa: a review
- COVID-19 vaccine trials with children: ethics pointers
- Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research
- Vaccine testing for emerging infections: the case for individual randomisation
- Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey
- Review of COVID-19 vaccine subtypes, efficacy and geographical distributions